What are the major opportunities in the Age-Related Macular Degeneration market? What are the strategies for the Age-Related Macular Degeneration market?

For detailed insights on the major opportunities and strategies in the Age-Related Macular Degeneration market, Read More

How does the Age-Related Macular Degeneration market relate to the overall economy and other similar markets?

For detailed insights on Age-Related Macular Degeneration's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Age-Related Macular Degeneration market growth? SWOT analysis of the Age-Related Macular Degeneration market.

For detailed insights on the key dynamics influencing the Age-Related Macular Degeneration market growth and SWOT analysis of the Age-Related Macular Degeneration industry, Read More

Age-Related Macular Degeneration Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Age-Related Macular Degeneration Market Report 2026

Name: Age-Related Macular Degeneration Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)), By Drug (Eylea, Lucentis, Avastin, Other Drugs), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Age-Related Macular Degeneration Market Overview

• Age-Related Macular Degeneration market size has reached to $10.67 billion in 2025

• Expected to grow to $15.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%

• Growth Driver: The Surging Prevalence Of Age-Related Macular Degeneration Sparks Growth In The AMD Market

• Market Trend: Advancements in AMD Therapy: The Role of Fab and MAR Systems

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Age-Related Macular Degeneration Market?

Age-related macular degeneration (AMD) refers to a progressive eye condition in which the macula, which is located at the center of the retina, deteriorates over time in individuals with AMD, leading to a decline in central vision. It is due to aging. The therapy options for age-related macular degeneration include regular eye exams, lifestyle changes, and particular nutritional supplements.

The main types of age-related macular degeneration are wet age-related macular degeneration (AMD) and dry age-related macular degeneration (AMD). Wet age-related macular degeneration refers to a progressive eye disease in which abnormal blood vessels start growing beneath the macula, which is the central part of the retina responsible for sharp, central vision. It uses various drugs such as eylea, lucentis, vastin, and others. It is applied intravenously and intravitreally, and are distributed through hospital pharmacies, specialty pharmacies, and online pharmacies.

Age-Related Macular Degeneration Market Global Report 2026 Market Report bar graph

What Is The Age-Related Macular Degeneration Market Size and Share 2026?

The age-related macular degeneration market size has grown strongly in recent years. It will grow from $10.67 billion in 2025 to $11.46 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to aging population globally, rising prevalence of amd, limited treatment options in early years, growing awareness of eye health, increasing hospital and ophthalmology clinic infrastructure.

What Is The Age-Related Macular Degeneration Market Growth Forecast?

The age-related macular degeneration market size is expected to see strong growth in the next few years. It will grow to $15.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of next-generation anti-vegf drugs, growing investment in ophthalmology research, expansion of specialty pharmacies and online pharmacy channels, increasing use of combination therapies, rising adoption of personalized treatment approaches. Major trends in the forecast period include increasing adoption of anti-vegf therapies, rising use of nutritional supplements and low vision aids, growth in photodynamic and laser therapy procedures, expansion of intravitreal and intravenous administration routes, increasing awareness and regular eye screening programs.

Book your 30 minutes free consultation with our research experts

Global Age-Related Macular Degeneration Market Segmentation

1) By Type: Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)

2) By Drug: Eylea, Lucentis, Avastin, Other Drugs

3) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy

Subsegments:

1) By Wet Age-Related Macular Degeneration (AMD): Anti-VEGF Injections, Photodynamic Therapy, Laser Surgery

2) By Dry Age-Related Macular Degeneration (AMD): Nutritional Supplements, Low Vision Aids, Therapies For Geographic Atrophy

What Is The Driver Of The Age-Related Macular Degeneration Market?

Rising age-related macular degeneration (AMD) prevalence is expected to propel the growth of the age-related macular degeneration (AMD) market going forward. Age-related macular degeneration (AMD) is a progressive eye condition affecting the macula, a small part of the retina responsible for central vision. Age-related macular degeneration (AMD) treatments support patients suffering from retinal disorders by minimizing the severity of the disease condition. For instance, in February 2023, according to the reports shared by Optimaxa, a UK-based laser eye treatment specialist, age-related macular degeneration (AMD) affected 196 million individuals globally and is expected to reach 288 million in 2040, accounting for 8.7 percent of the world's population. Therefore, rising age-related macular degeneration (AMD) prevalence is driving the age-related macular degeneration industry.

Key Players In The Global Age-Related Macular Degeneration Market

Major companies operating in the age-related macular degeneration market are F. Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., Outlook Therapeutics Inc., Samsung Bioepis Co. Ltd., Biocon Ltd., Bio-Thera Biopharmaceutical Co. Ltd., Acucela Inc., Ophthotech Corporation, Kodiak Sciences Inc., REGENXBIO Inc., Alkahest Inc., Opthea Limited, Apellis Pharmaceuticals Inc., Graybug Vision Inc., IVERIC bio Inc., Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., Chengdu Kanghong Pharmaceutical Group Co. Ltd., pSivida Corp., Clearside Biomedical Inc., SciFluor Life Sciences LLC, Lineage Cell Therapeutics Inc.

Global Age-Related Macular Degeneration Market Trends and Insights

Major companies in the age-related macular degeneration (AMD) market are advancing innovative technologies, such as recombinant antigen-binding fragments. Recombinant antigen-binding fragments (Fab) are engineered proteins derived from antibodies that specifically bind to target antigens, commonly utilized in therapeutic applications to inhibit disease-related pathways. For instance, in December 2023, Enzene Biosciences, an India-based biotechnology company, launched ranibizumab, a recombinant monoclonal antibody fragment (Fab) specifically engineered to inhibit vascular endothelial growth factor (VEGF), a key protein involved in the development of abnormal blood vessels in conditions such as age-related macular degeneration (AMD) and diabetic macular edema (DME). By obstructing VEGF, ranibizumab effectively decreases the leakage and proliferation of these blood vessels, which helps preserve vision in patients with these retinal disorders. It is delivered through intravitreal injection and has gained widespread acceptance in clinical practice for its efficacy in treating various retinal diseases. The introduction of ranibizumab has greatly enhanced the treatment landscape for patients grappling with these serious conditions.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Age-Related Macular Degeneration Market?

In May 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, acquired IVERIC Bio Inc., for $5.9 billion. Through this acquisition, Astellas Pharma Inc. aims to expand its presence in the ophthalmology market and accelerate the development of novel treatments in the field of ophthalmology. IVERIC Bio Inc. is a US-based biotech corporation that develops age-related macular degeneration drugs and products for treatment.

Regional Outlook

North America was the largest region in the global age-related macular degeneration market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Age-Related Macular Degeneration Market?

The age-related macular degeneration market consists of sales of anti-vascular endothelial growth factor (anti-VEGF) drugs, photodynamic therapy (PDT), low-vision aids, and telescopic lenses. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Age-Related Macular Degeneration Market Report 2026?

The age-related macular degeneration market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the age-related macular degeneration industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Age-Related Macular Degeneration Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$11.46 billion
Revenue Forecast In 2035	$15.42 billion
Growth Rate	CAGR of 7.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Drug, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., Outlook Therapeutics Inc., Samsung Bioepis Co. Ltd., Biocon Ltd., Bio-Thera Biopharmaceutical Co. Ltd., Acucela Inc., Ophthotech Corporation, Kodiak Sciences Inc., REGENXBIO Inc., Alkahest Inc., Opthea Limited, Apellis Pharmaceuticals Inc., Graybug Vision Inc., IVERIC bio Inc., Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., Chengdu Kanghong Pharmaceutical Group Co. Ltd., pSivida Corp., Clearside Biomedical Inc., SciFluor Life Sciences LLC, Lineage Cell Therapeutics Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Age-Related Macular Degeneration Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Age-Related Macular Degeneration Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Age-Related Macular Degeneration Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Age-Related Macular Degeneration Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Anti-Vegf Therapies

4.2.2 Rising Use Of Nutritional Supplements And Low Vision Aids

4.2.3 Growth In Photodynamic And Laser Therapy Procedures

4.2.4 Expansion Of Intravitreal And Intravenous Administration Routes

4.2.5 Increasing Awareness And Regular Eye Screening Programs

5. Age-Related Macular Degeneration Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Ophthalmology Centers

5.3 Specialty Pharmacies

5.4 Online Pharmacies

5.5 Research And Academic Institutions

6. Age-Related Macular Degeneration Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Age-Related Macular Degeneration Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Age-Related Macular Degeneration PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Age-Related Macular Degeneration Market Size, Comparisons And Growth Rate Analysis

7.3. Global Age-Related Macular Degeneration Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Age-Related Macular Degeneration Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Age-Related Macular Degeneration Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Age-Related Macular Degeneration Market Segmentation

9.1. Global Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)

9.2. Global Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Eylea, Lucentis, Avastin, Other Drugs

9.3. Global Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Specialty Pharmacy

9.4. Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-VEGF Injections, Photodynamic Therapy, Laser Surgery

9.5. Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nutritional Supplements, Low Vision Aids, Therapies For Geographic Atrophy

10. Age-Related Macular Degeneration Market Regional And Country Analysis

10.1. Global Age-Related Macular Degeneration Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Age-Related Macular Degeneration Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Age-Related Macular Degeneration Market

11.1. Asia-Pacific Age-Related Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Age-Related Macular Degeneration Market

12.1. China Age-Related Macular Degeneration Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Age-Related Macular Degeneration Market

13.1. India Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Age-Related Macular Degeneration Market

14.1. Japan Age-Related Macular Degeneration Market Overview

14.2. Japan Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Age-Related Macular Degeneration Market

15.1. Australia Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Age-Related Macular Degeneration Market

16.1. Indonesia Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Age-Related Macular Degeneration Market

17.1. South Korea Age-Related Macular Degeneration Market Overview

17.2. South Korea Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Age-Related Macular Degeneration Market

18.1. Taiwan Age-Related Macular Degeneration Market Overview

18.2. Taiwan Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Age-Related Macular Degeneration Market

19.1. South East Asia Age-Related Macular Degeneration Market Overview

19.2. South East Asia Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Age-Related Macular Degeneration Market

20.1. Western Europe Age-Related Macular Degeneration Market Overview

20.2. Western Europe Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Age-Related Macular Degeneration Market

21.1. UK Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Age-Related Macular Degeneration Market

22.1. Germany Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Age-Related Macular Degeneration Market

23.1. France Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Age-Related Macular Degeneration Market

24.1. Italy Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Age-Related Macular Degeneration Market

25.1. Spain Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Age-Related Macular Degeneration Market

26.1. Eastern Europe Age-Related Macular Degeneration Market Overview

26.2. Eastern Europe Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Age-Related Macular Degeneration Market

27.1. Russia Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Age-Related Macular Degeneration Market

28.1. North America Age-Related Macular Degeneration Market Overview

28.2. North America Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Age-Related Macular Degeneration Market

29.1. USA Age-Related Macular Degeneration Market Overview

29.2. USA Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Age-Related Macular Degeneration Market

30.1. Canada Age-Related Macular Degeneration Market Overview

30.2. Canada Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Age-Related Macular Degeneration Market

31.1. South America Age-Related Macular Degeneration Market Overview

31.2. South America Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Age-Related Macular Degeneration Market

32.1. Brazil Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Age-Related Macular Degeneration Market

33.1. Middle East Age-Related Macular Degeneration Market Overview

33.2. Middle East Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Age-Related Macular Degeneration Market

34.1. Africa Age-Related Macular Degeneration Market Overview

34.2. Africa Age-Related Macular Degeneration Market, Segmentation By Type, Segmentation By Drug, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Age-Related Macular Degeneration Market Regulatory and Investment Landscape

36. Age-Related Macular Degeneration Market Competitive Landscape And Company Profiles

36.1. Age-Related Macular Degeneration Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Age-Related Macular Degeneration Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Age-Related Macular Degeneration Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Age-Related Macular Degeneration Market Other Major And Innovative Companies

Regeneron Pharmaceuticals Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., Outlook Therapeutics Inc., Samsung Bioepis Co. Ltd., Biocon Ltd., Bio-Thera Biopharmaceutical Co. Ltd., Acucela Inc., Ophthotech Corporation, Kodiak Sciences Inc., REGENXBIO Inc., Alkahest Inc., Opthea Limited, Apellis Pharmaceuticals Inc., Graybug Vision Inc.

38. Global Age-Related Macular Degeneration Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Age-Related Macular Degeneration Market

40. Age-Related Macular Degeneration Market High Potential Countries, Segments and Strategies

40.1 Age-Related Macular Degeneration Market In 2030 - Countries Offering Most New Opportunities

40.2 Age-Related Macular Degeneration Market In 2030 - Segments Offering Most New Opportunities

40.3 Age-Related Macular Degeneration Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Age-Related Macular Degeneration Market, Overview Of Key Products - Product Examples

Table 2: Global Age-Related Macular Degeneration Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Age-Related Macular Degeneration Market, Supply Chain Analysis

Table 4: Global Age-Related Macular Degeneration Market, Major Raw Material Providers

Table 5: Global Age-Related Macular Degeneration Market, Major Resource Providers

Table 6: Global Age-Related Macular Degeneration Market, Major Manufacturers (Suppliers)

Table 7: Global Age-Related Macular Degeneration Market, Major Distributors And Channel Partners

Table 8: Global Age-Related Macular Degeneration Market, Key Technologies & Future Trends

Table 9: Global Age-Related Macular Degeneration Market, Major Trends

Table 10: Global Age-Related Macular Degeneration Market, Major End Users

Table 11: Global Age-Related Macular Degeneration Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Age-Related Macular Degeneration Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Age-Related Macular Degeneration Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Age-Related Macular Degeneration Market - TAM, US$ Billion, 2025

Table 15: Global Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Age-Related Macular Degeneration Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Age-Related Macular Degeneration Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Age-Related Macular Degeneration Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Age-Related Macular Degeneration Market - Company Scoring Matrix

Table 96: F. Hoffmann-La Roche Ltd. Financial Performance

Table 97: Novartis AG Financial Performance

Table 98: Bayer AG Financial Performance

Table 99: Pfizer Inc. Financial Performance

Table 100: Bausch Health Companies Inc. Financial Performance

Table 101: Global Age-Related Macular Degeneration Market, Competitive Benchmarking (In USD Billions)

Table 102: Global Age-Related Macular Degeneration Market, Competitive Dashboard

Table 103: Global Age-Related Macular Degeneration Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, Age-Related Macular Degeneration Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 105: Global, Age-Related Macular Degeneration Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030

Table 106: Global, Age-Related Macular Degeneration Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Age-Related Macular Degeneration Market, Overview Of Key Products - Product Examples

Figure 2: Global Age-Related Macular Degeneration Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Age-Related Macular Degeneration Market, Supply Chain Analysis

Figure 4: Global Age-Related Macular Degeneration Market, Major Raw Material Providers

Figure 5: Global Age-Related Macular Degeneration Market, Major Resource Providers

Figure 6: Global Age-Related Macular Degeneration Market, Major Manufacturers (Suppliers)

Figure 7: Global Age-Related Macular Degeneration Market, Major Distributors And Channel Partners

Figure 8: Global Age-Related Macular Degeneration Market, Key Technologies & Future Trends

Figure 9: Global Age-Related Macular Degeneration Market, Major Trends

Figure 10: Global Age-Related Macular Degeneration Market, Major End Users

Figure 11: Global Age-Related Macular Degeneration Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Age-Related Macular Degeneration Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Age-Related Macular Degeneration Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Age-Related Macular Degeneration Market - TAM, US$ Billion, 2025

Figure 15: Global Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Age-Related Macular Degeneration Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Age-Related Macular Degeneration Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Age-Related Macular Degeneration Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Age-Related Macular Degeneration Market - Company Scoring Matrix

Figure 96: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 97: Novartis AG Financial Performance

Figure 98: Bayer AG Financial Performance

Figure 99: Pfizer Inc. Financial Performance

Figure 100: Bausch Health Companies Inc. Financial Performance

Figure 101: Global Age-Related Macular Degeneration Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global Age-Related Macular Degeneration Market, Competitive Dashboard

Figure 103: Global Age-Related Macular Degeneration Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, Age-Related Macular Degeneration Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 105: Global, Age-Related Macular Degeneration Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030

Figure 106: Global, Age-Related Macular Degeneration Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Macular Degeneration Treatment Market Report 2026 - Global Outlook – By Stage of Disease (Early-Stage AMD, Intermediate AMD, Late-Stage AMD), By Route of Administration (Oral, Injectable, Other Routes of Administration),...

Macular Edema and Macular Degeneration Market Report 2026 - Global Outlook – By Treatment Type (Drug Therapy, Laser Treatment), By Application (Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Ma...

Non-Proliferative Diabetic Retinopathy Market Report 2026 - Global Outlook – By Treatment Type (Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Diseas...

Retinal Disorder Treatment Market Report 2026 - Global Outlook – By Type (Macular Degeneration, Diabetic Retinopathy, Other Types), By Dosage Form (Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments), By Dis...

Diabetic Retinopathy Market Report 2026 - Global Outlook – By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy), By Treatment (Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photoco...

Retinal Biologics Market Report 2026 - Global Outlook – By Drug Class (Vascular Endothelial Growth Factor (VEGF)-A Antagonist, Tumor Necrosis Factor (TNF)-A Inhibitor), By Indication (Macular Degeneration, Diabetic Retin...

Optic Atrophy Management Market Report 2026 - Global Outlook – By Drug Type (Disulfiram, Amebicides, Ethambutol, Isoniazid, Chloramphenicol, Vincristine, Ciclosporin, Cimetidine), By Route Of Administration (Oral, Inject...

Frequently Asked Questions

What is the projected market size of the Age-Related Macular Degeneration Market Report 2026 market by 2030?

The Age-Related Macular Degeneration Market Report 2026 market was valued at $10.67 billion in 2025, increased to $11.46 billion in 2026, and is projected to reach $15.42 billion by 2030. request a sample here

What is the expected CAGR for the Age-Related Macular Degeneration Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Age-Related Macular Degeneration Market Report 2026 market during the forecast period 2025–2030 is 7.7%. request a sample here

What are the key factors driving the Age-Related Macular Degeneration Market Report 2026 market?

Major growth driver of the market includes: The Surging Prevalence Of Age-Related Macular Degeneration Sparks Growth In The AMD Market in the Age-Related Macular Degeneration Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Age-Related Macular Degeneration Market Report 2026 market report?

The age-related macular degeneration market covered in this report is segmented –
1) By Type: Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)
2) By Drug: Eylea, Lucentis, Avastin, Other Drugs
3) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy Subsegments:
1) By Wet Age-Related Macular Degeneration (AMD): Anti-VEGF Injections, Photodynamic Therapy, Laser Surgery
2) By Dry Age-Related Macular Degeneration (AMD): Nutritional Supplements, Low Vision Aids, Therapies For Geographic Atrophy request a sample here

What is the anticipated growth trend for the Age-Related Macular Degeneration Market Report 2026 market?

Major trend in this market includes: Advancements in AMD Therapy: The Role of Fab and MAR Systems For further insights on this market, request a sample here.

Who are the key players in the Age-Related Macular Degeneration Market Report 2026 market?

Major companies operating in the Age-Related Macular Degeneration Market Report 2026 market are Major companies operating in the age-related macular degeneration market are F. Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., Outlook Therapeutics Inc., Samsung Bioepis Co. Ltd., Biocon Ltd., Bio-Thera Biopharmaceutical Co. Ltd., Acucela Inc., Ophthotech Corporation, Kodiak Sciences Inc., REGENXBIO Inc., Alkahest Inc., Opthea Limited, Apellis Pharmaceuticals Inc., Graybug Vision Inc., IVERIC bio Inc., Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., Chengdu Kanghong Pharmaceutical Group Co. Ltd., pSivida Corp., Clearside Biomedical Inc., SciFluor Life Sciences LLC, Lineage Cell Therapeutics Inc. request a sample here.

Which region has the most growth potential in the Age-Related Macular Degeneration Market Report 2026 market?

North America was the largest region in the global age-related macular degeneration market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the age-related macular degeneration market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.